Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Associated Press - Tuesday November 21, 2000
The Leverkusen-based company, best-known for developing aspirin, will look for substances effective against resistant viruses, said Wolfgang Hartwig, head of research in Bayer's pharmaceutical business group.
The company declined to specify how much it will invest in AIDS research. In 2000, it budgeted a total of 1 billion euros ($845 million) for research and development.
Bayer said it expects to identify the first substances suitable for preclinical HIV testing within two years.
Pharmaceutical research will in the future be focused on 13 fields, including seeking new treatments in urology, Alzheimer's dementia and Parkinson's disease. Bayer said it will stop its research activities for osteoporosis, fibrosis of the liver and stroke.
001121
AP001110
Copyright © 2000 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .